FocusPerformancePartnership

Astorg VII closes at its €4 billion hard cap

Publishing Date January 10, 2019

Last Updated September 30, 2026

Corporate News3 Mins Read

Publishing Date January 10, 2019

Last Updated September 30, 2026

3 Mins ReadCorporate News

European private equity firm Astorg announces the final close of Astorg VII at €4.0 billion, above the initial target of €3.2 billion, and in line with the fundraising hard cap established by the management company.

Amidst very strong demand from both existing and new investors, the fund was substantially oversubscribed and the sole closing occurred only three months after the launch of its subscription. The fund has thus reached twice the size of its predecessor Astorg VI, which is more than 80% invested.

Astorg VII is backed by a global and diverse investor base, including public and corporate pension funds (32%), institutional asset managers (21%), insurance companies (16%) and Sovereign Wealth Funds (10%) located in Europe (58%), North America (29%) and Asia (13%). Demand from existing investors alone exceeded Astorg VII’s target of €3.2billion, with more than 90% by number returning in the new fund.

Over the past 20 years, Astorg has become one of the leading private equity firms in Europe by implementing its uniquely focused investment strategy of targeting B2B global niche market leaders. The team of 80 people from 14 different nationalities, including 42 investment professionals, based in Luxembourg, Paris, London, Frankfurt and Milan, will continue to invest Astorg VII along this proven and successful strategy. Astorg VII will be deployed mainly in European companies with a value of between €200 million and €2 billion, and more occasionally in companies operating in the healthcare and software sectors in the US.

Over the past twenty years, Astorg enjoys a strong track record across multiple investment cycles. Among the 34 investments that have been completed since its creation, Astorg has generated an average IRR of 27.1% gross and an average multiple on invested capital of 2.6x, which attests to the relevance of its investment strategy and the expertise and skills of its team.

Thierry Timsit, CEO and Managing Partner, said: “Astorg VII represents a significant milestone in our development, positioning Astorg as a leading European investment firm. The strong demand we have received reflects the confidence of investors in our team, the robustness of our track record, and the quality of the partnering management teams. We are grateful for the massive support of our existing investors, and humbled by the trust we received from numerous new investors. We will deploy this fund using the three pillars that made Astorg successful in the past: our investment strategy, our ability to transform and strengthen the companies we acquire, and our entrepreneurial DNA, which connects us well with company founders and like-minded management teams.”

Jeff Orenstein, Head of Client Relations, added: “We are delighted and grateful for the support Astorg VII has received from a deep bench of recognised global blue chip investors. The successful fundraising is, at foremost, a reflection of the quality of the Astorg team, who has stringently adhered to Astorg’s disciplined investment philosophy, ESG care, and portfolio value creation, delivering a consistency of strong performance over twenty years and through multiple investment cycles.”

About Astorg

Astorg

Astorg is a European private equity firm with total funds under management of over €7 billion. Astorg seeks to partner with entrepreneurial management teams to acquire European companies and create value through the provision of strategic guidance, experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Though not specialized, Astorg has gathered valuable industry expertise in healthcare, business-to-business professional services and technology-based industrial companies. Astorg has offices in London, Paris, Luxembourg, Frankfurt and Milan, as well as Senior Advisors based in Zurich, Paris and London.

For further information about Astorg: www.astorg.com

Further Information

Delivering consistent performance
across every investment

Related Hub content

Astorg announces final closing for Astorg VIII, reaching total capital committed of €4.4bn.   Astorg expands its Executive Committee
ViewMore
Corporate News
news
Astorg announces final closing for Astorg VIII, reaching total capital committed of €4.4bn. Astorg expands its Executive Committee
Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
ViewMore
Corporate News
news
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
Astorg announces final closing for Astorg VIII, reaching total capital committed of €4.4bn.   Astorg expands its Executive Committee
ViewMore
Corporate News
news
Astorg announces final closing for Astorg VIII, reaching total capital committed of €4.4bn. Astorg expands its Executive Committee
Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate
ViewMore
Corporate News
news
Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate